宣泰医药：栖和创业本次质押股份1000万股

Group 1 - The core point of the announcement is that Nanjing Qihe Venture Capital Partnership holds approximately 23.1 million shares of Xuantai Pharmaceutical, accounting for 5.1% of the total share capital, and has pledged 10 million shares, which is 43.28% of its holdings and 2.21% of the total share capital [1] - After the pledge, the total pledged shares amount to 22 million, representing 95.22% of Nanjing Qihe's holdings and 4.85% of the total share capital [1] - For the fiscal year 2024, Xuantai Pharmaceutical's revenue composition is heavily weighted towards the pharmaceutical manufacturing sector, which accounts for 99.89% of total revenue, while other businesses contribute only 0.11% [1] Group 2 - The current market capitalization of Xuantai Pharmaceutical is 4.9 billion yuan [2]